Table 1.
Summary of the demographic characteristics of participants
| Study | Participants | Study design | Participant characteristics | Age [years] | Outcomes |
|---|---|---|---|---|---|
| Benavente et al. [43] | 13 (males) | Within-subject, counterbalanced, Pre–post-comparison | Resistance trained | 22.31 ± 2.59 | TNF-α, IL-10 |
| Blegen et al. [42] | 9 (males) | Within-subject, Pre–post-comparison | Healthy | 27.00 ± 4.40 | TNF-α |
| Britto et al. [38] | 20 (males) | Between-subject, Pre–post-comparison | Healthy | 22.20 ± 1.79 | TNF-α, IL-10 |
| Caris et al. [44] | 7 (males) | Within-subject, Pre–post-comparison | Healthy | 23.00 ± 2.00 | IL-6, TNF-α, IL-10 |
| Chen et al. [37] | 11 (males) | Within-subject, Pre–post-comparison | Swimmer | 21.40 ± 0.99 | IL-6 |
| Goods et al. [45] | 10 (males) | Within-subject, Pre–post-comparison | Footballers | 20.50 ± 1.90 | IL-6 |
| Goto et al. [40] | 10 (males) | Within-subject, Pre–post-comparison | Endurance athletes | 19.80 ± 0.90 | IL-6 |
| Goto et al. [46] | 10 (males) | Within-subject, Pre–post-comparison | Track-and-field sprinters | 20.90 ± 0.30 | IL-6 |
| Govus et al. [54] | 13 (male = 7, female = 6) | Within-subject, counterbalanced, Pre–post-comparison | Endurance trained and triathlete | 28.80 ± 5.30 | IL-6 |
| Hagobian et al. [47] | 8 (males) | Within-subject, Pre–post-comparison | Trained | 24.80 ± 4.00 | TNF-α |
| Hill et al. [55] | 10 (male = 9, female = 1) | Within-subject, counterbalanced, Pre–post-comparison | Physically active | 21.00 ± 3.16 | IL-6, TNF-α, IL-10 |
| Lee et al. [48] | 12 (males) | Within-subject, Pre–post-comparison | Healthy | 22.00 ± 4.00 | IL-6, TNF-α, IL-10 |
| Liara et al. [39] | 14 (males) | Between-subject, Pre–post-comparison | Healthy |
NOR:25.83 ± 2.90 HYP:24.00 ± 2.34 |
IL-6, TNF-α, IL-10 |
| Lundby 2004 [56] | 8 (male = 6, female = 2) | Within-subject, Pre–post-comparison | Trained | 25.00 ± 1.00 | IL-6 |
| Mazzeo et al. [49] | 8 (males) | Within-subject, Pre–post-comparison | Healthy | 23.20 ± 5.60 | IL-6 |
| Morrison et al. [58] | 11 (ND) | Within-subject, Pre–post-comparison | Footballers | 24.20 ± 4.70 | IL-6, TNF-α, IL-10 |
| Moura et al. [41] | 7 (male = 5, female = 2) | Within-subject, Pre–post-comparison | Healthy | 41.00 ± 8.00 | IL-6 |
| Santos et al. [29] | 9 (males) | Within-subject, Pre–post-comparison | Healthy | 24.20 ± 2.17 | IL-6, TNF-α, IL-10 |
| Santos et al. [50] | 8 (males) | Within-subject, Pre–post-comparison | Healthy | 24.40 ± 3.80 | IL-6, TNF-α, IL-10 |
| Sevendsen et al. [51] | 12 (males) | Within-subject, Pre–post-comparison | Endurance athlete | 28.00 ± 4.00 | IL-6, TNF-α, IL-10 |
| Wahl et al. [52] | 7 (males) | Within-subject, Pre–post-comparison | Healthy | 22.10 ± 1.90 | IL-6 |
| Żebrowska et al. [53] | 12 (males) | Within-subject, Pre–post-comparison | Healthy | 24.40 ± 4.00 | IL-6, TNF-α |
| Żebrowska et al. [57] | 14 (male = 9, female = 5) | Within-subject, Pre–post-comparison | Healthy | 27.10 ± 3.90 | IL-6, TNF-α |
IL-6 interleukin 6, TNFα tumor necrosis factor-α, IL-10 interleukin 10, ND not-described